SCHEMBL13071435

SCHEMBL13071435

CC(C)(C)Cn1c(O)nc2ccccc21

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
GAA P10253 1/20 0.47
PKM P14618 1/20 0.47
CYP1A2 P05177 1/20 0.45
CYP2D6 P10635 1/20 0.45
HTT P42858 1/20 0.45
APAF1 O14727 1/20 0.43
POLB P06746 3/20 0.43
LMNA P02545 2/20 0.43
ALDH1A1 P00352 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
TNF P01375 1/20 0.42
F2R P25116 1/20 0.41
CXCR4 P61073 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
MAPK1 P28482 1/20 0.41
CASP1 P29466 1/20 0.41
CASP7 P55210 1/20 0.41
HPGD P15428 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13071432 0.83 CYP2C9 (0.44) MEN1KMT2ACYP1A2CYP2D6HTT
SCHEMBL13111951 0.81 TNF (0.60) PKMHTTAPAF1LMNAALDH1A1
SCHEMBL12397237 0.80 HTT (0.62) MEN1KMT2AGAAPKMCYP1A2
SCHEMBL990194 0.79 HTT (0.67) KMT2ACYP1A2CYP2D6HTTPOLB
SCHEMBL1537674 0.79 SMN1; SMN2 (0.55) MEN1KMT2AGAAPKMCYP1A2
SCHEMBL15978916 0.78 MEN1 (0.68) MEN1KMT2AGAAPKMCYP1A2
SCHEMBL2464947 0.77 HPGD (0.64) MEN1KMT2AGAACYP1A2HTT
SCHEMBL13071434 0.76 LMNA (0.56) MEN1KMT2AGAAHTTAPAF1
SCHEMBL16741955 0.76 L3MBTL1 (0.46) MEN1KMT2AGAAPKMHTT
SCHEMBL152719 0.74 TNF (0.65) MEN1KMT2ACYP1A2CYP2D6HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009142842-A9 NOVEL MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION INTERMUNE, INC. (US) 2010-11-25 WO disclosed
WO-2009142842-A2 NOVEL MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION INTERMUNE, INC. (US) 2009-11-26 WO disclosed